Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Elevation Oncology Inc.

    NASDAQ: ELEV · Real-Time Price · USD
    0.38
    0.06 (18.79%)
    At close: Jun 09, 2025, 3:59 PM

    Elevation Oncology Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 n/a 39K 27K 18K
    Gross Profit
    		 n/a -39K -27K -18K
    Operating Income
    		 -44.7M -45.45M -94.55M -32.05M
    Interest Income
    		 n/a 3.9M n/a n/a
    Pretax Income
    		 -44.44M -45.67M -95.06M -32.04M
    Net Income
    		 -44.48M -45.7M -95.08M -32.04M
    Selling & General & Admin
    		 16.11M 14.9M 15.83M 8.45M
    Research & Development
    		 28.6M 25.43M 78.72M 23.59M
    Other Expenses
    		 n/a 5.11M -506K 7K
    Operating Expenses
    		 44.7M 45.45M 94.55M 32.05M
    Interest Expense
    		 1.2M 4.17M 479K n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 -44.7M 45.45M 94.55M 32.05M
    Income Tax Expense
    		 43K 30K 25K -218.56K
    Shares Outstanding (Basic)
    		 57.28M 34.08M 23.27M 23.21M
    Shares Outstanding (Diluted)
    		 57.28M 34.08M 23.27M 23.21M
    EPS (Basic)
    		 -0.78 -1.34 -4.09 -1.38
    EPS (Diluted)
    		 -0.78 -1.34 -4.09 -1.38
    EBITDA
    		 -44.7M -41.47M -94.52M -32.03M
    EBIT
    		 -43.24M -41.51M -94.55M -32.05M
    Depreciation & Amortization
    		 -1.46M 39K 27K 18K

    Add to Watchlist